-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
CHILD-INNOVAC project demonstrates effective nasal vaccine against pertussis in Phase I trial
News and Views: Clinical Investigation
-
CHILD-INNOVAC project demonstrates effective nasal vaccine against pertussis in Phase I trial
News and Views: Clinical Investigation
-
CHILD-INNOVAC project demonstrates effective nasal vaccine against pertussis in Phase I trial
News and Views: Clinical Investigation
-
CHILD-INNOVAC project demonstrates effective nasal vaccine against pertussis in Phase I trial
News and Views: Clinical Investigation
-
CHILD-INNOVAC project demonstrates effective nasal vaccine against pertussis in Phase I trial
News and Views: Clinical Investigation
-
CHILD-INNOVAC project demonstrates effective nasal vaccine against pertussis in Phase I trial
News and Views: Clinical Investigation
-
CHILD-INNOVAC project demonstrates effective nasal vaccine against pertussis in Phase I trial
News and Views: Clinical Investigation
-
CHILD-INNOVAC project demonstrates effective nasal vaccine against pertussis in Phase I trial
News and Views: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Anti-cancer potential of tumor-vascular disrupting agents: review of the latest clinical evidence
Bruce C Baguley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Anti-cancer potential of tumor-vascular disrupting agents: review of the latest clinical evidence
Bruce C Baguley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Anti-cancer potential of tumor-vascular disrupting agents: review of the latest clinical evidence
Bruce C Baguley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Anti-cancer potential of tumor-vascular disrupting agents: review of the latest clinical evidence
Bruce C Baguley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Anti-cancer potential of tumor-vascular disrupting agents: review of the latest clinical evidence
Bruce C Baguley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Anti-cancer potential of tumor-vascular disrupting agents: review of the latest clinical evidence
Bruce C Baguley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Anti-cancer potential of tumor-vascular disrupting agents: review of the latest clinical evidence
Bruce C Baguley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Anti-cancer potential of tumor-vascular disrupting agents: review of the latest clinical evidence
Bruce C Baguley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
Research Update: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for amyotrophic lateral sclerosis
James D Berry, Merit E Cudkowicz
Review Article: Clinical Investigation